Journal Of Pharmaceutical And Biomedical Analysis SCIE

國(guó)際簡(jiǎn)稱：J PHARMACEUT BIOMED 參考譯名：醫(yī)藥與生物醫(yī)學(xué)分析雜志

主要研究方向：醫(yī)學(xué)-分析化學(xué) 非預(yù)警期刊審稿周期：約2.0個(gè)月約6.5周

《醫(yī)藥與生物醫(yī)學(xué)分析雜志》(Journal Of Pharmaceutical And Biomedical Analysis)是一本由Elsevier出版的以醫(yī)學(xué)-分析化學(xué)為研究特色的國(guó)際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評(píng)論文章和綜述文章，及時(shí)報(bào)道該領(lǐng)域相關(guān)理論、實(shí)踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開(kāi)放期刊，近三年沒(méi)有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
589 年發(fā)文量
3.1 IF影響因子
未開(kāi)放 是否OA
114 H-index
1983 創(chuàng)刊年份
Semimonthly 出版周期
English 出版語(yǔ)言

This journal is an international medium directed towards the needs of academic, clinical, government and industrial analysis by publishing original research reports and critical reviews on pharmaceutical and biomedical analysis. It covers the interdisciplinary aspects of analysis in the pharmaceutical, biomedical and clinical sciences, including developments in analytical methodology, instrumentation, computation and interpretation. Submissions on novel applications focusing on drug purity and stability studies, pharmacokinetics, therapeutic monitoring, metabolic profiling; drug-related aspects of analytical biochemistry and forensic toxicology; quality assurance in the pharmaceutical industry are also welcome.

Studies from areas of well established and poorly selective methods, such as UV-VIS spectrophotometry (including derivative and multi-wavelength measurements), basic electroanalytical (potentiometric, polarographic and voltammetric) methods, fluorimetry, flow-injection analysis, etc. are accepted for publication in exceptional cases only, if a unique and substantial advantage over presently known systems is demonstrated. The same applies to the assay of simple drug formulations by any kind of methods and the determination of drugs in biological samples based merely on spiked samples. Drug purity/stability studies should contain information on the structure elucidation of the impurities/degradants.

[ 查看全部 ]

投稿咨詢加急咨詢

Journal Of Pharmaceutical And Biomedical Analysis期刊信息

ISSN：0731-7085
出版語(yǔ)言：English
是否OA：未開(kāi)放
E-ISSN：1873-264X
出版地區(qū)：NETHERLANDS
是否預(yù)警：否
出版商：Elsevier
出版周期：Semimonthly
創(chuàng)刊時(shí)間：1983
開(kāi)源占比：0.0651
Gold OA文章占比：12.62%
OA被引用占比：0.0203...
出版國(guó)人文章占比：0.27
出版撤稿占比：0
研究類文章占比：98.81%

Journal Of Pharmaceutical And Biomedical Analysis CiteScore評(píng)價(jià)數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

6.7

0.584

0.927

學(xué)科類別	分區(qū)	排名	百分位
大類：Chemistry 小類：Spectroscopy	Q1	18 / 76	76%
大類：Chemistry 小類：Pharmaceutical Science	Q1	46 / 183	75%
大類：Chemistry 小類：Analytical Chemistry	Q2	40 / 156	74%
大類：Chemistry 小類：Clinical Biochemistry	Q2	37 / 117	68%
大類：Chemistry 小類：Drug Discovery	Q2	52 / 157	67%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個(gè)指標(biāo)。當(dāng)年CiteScore 的計(jì)算依據(jù)是期刊最近4年（含計(jì)算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計(jì)算方法為：2022年的 CiteScore =2019-2022年收到的對(duì)2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評(píng)論、會(huì)議論文、書籍章節(jié)和數(shù)據(jù)論文。

Journal Of Pharmaceutical And Biomedical Analysis中科院評(píng)價(jià)數(shù)據(jù)

中科院 2023年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 3區(qū)

中科院 2022年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 3區(qū)

中科院 2021年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 2區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 3區(qū)

中科院 2021年12月升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 2區(qū)

中科院 2020年12月舊的升級(jí)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	2區(qū)	CHEMISTRY, ANALYTICAL 分析化學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	2區(qū) 2區(qū)

Journal Of Pharmaceutical And Biomedical Analysis JCR評(píng)價(jià)數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CHEMISTRY, ANALYTICAL	SCIE	Q2	37 / 106	65.6%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	126 / 354	64.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CHEMISTRY, ANALYTICAL	SCIE	Q1	25 / 106	76.89%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.48%

Journal Of Pharmaceutical And Biomedical Analysis歷年數(shù)據(jù)統(tǒng)計(jì)

影響因子

中科院分區(qū)

Journal Of Pharmaceutical And Biomedical Analysis中國(guó)學(xué)者發(fā)文選摘

1、Determination of olverembatinib in human plasma and cerebrospinal fluid by an LC-MS/MS method: Validation and clinical application
Author: Xiang, Dong; Zhao, Tinghui; Wang, Jue; Cao, Yang; Yu, Qiuxia; Liu, Lu; Yu, Hengyi; Li, Xiping; Li, Ninghong; Yi, Yang; Gong, Xuepeng

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 230, Issue , pp. -. DOI: 10.1016/j.jpba.2023.115382
2、Determination of CYP450 activities in diabetes mellitus rats by a UHPLC-MS/MS method
Author: Wang, Zhe; Li, Qing-qing; Huang, Cheng-ke; Dong, Yan-yan; Lang, Li-ping; Sun, Wei; Qian, Jian-chang; Zhang, Xiao-dan

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115191
3、Rapid identification, quantitation, and antioxidant activity evaluation of the components in Guanxin Shutong capsule with liquid chromatography and mass spectrometry
Author: Meng, Ming; Wan, Haofang; Bao, Yida; He, Yu; Li, Chang; Wan, Haitong

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115194
4、UPLC-Q-TOF-MS and UPLC-QQQ-MS were used for the qualitative and quantitative analysis of oligosaccharides in Fufang Ejiao Syrup
Author: Li, Wen; Wang, Yanping; Han, Jiabing; Zhang, Jinjin; Li, Bing; Qi, Xiaodan; Zhang, Yan; Hu, Fangdi; Liu, Haibin

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115193
5、Chemical profiling and quantification of Yihuang decoction by high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry and a diode array detector
Author: Zhou, Jinxin; Yu, Sheng; Wang, Bingqian; Wei, Xing; Zhang, Li; Shan, Mingqiu

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115199
6、Supported liquid extraction and ultra-high performance liquid chromatography-tandem mass spectrometry for the determination of urinary polycyclic aromatic hydrocarbon metabolites and their application for human biomonitoring
Author: Deng, Fenfang; Guo, Chongshan; Zeng, Wei; Zhong, Yi; Luo, Xiaoyan; Pan, Xinhong; Zhang, Lin; Tan, Lei

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115201
7、Pharmacokinetics and in vitro liver microsomal enzyme metabolism of Xylopic acid
Author: Alolga, Raphael N.; Wang, Shi-Lei; Ayensu, Isaac; Nebeolisa, Chiemezie S.

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 224, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115200
8、Use of chiral ionic liquid as additive for synergistic enantioseparation of basic drugs in capillary electrophoresis
Author: Zhang, Chengchen; Ma, Xiaofei

Journal: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. 2023; Vol. 225, Issue , pp. -. DOI: 10.1016/j.jpba.2022.115204